Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 387, Issue 2, Pages 197-204Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-2999(99)00706-2
Keywords
anxiety; depression; 5-HT2C receptor; (rat)
Categories
Ask authors/readers for more resources
There is some controversy as to whether 5-HT2C receptor agonists are anxiogenic or anxiolytic. The effects of the novel 5-HT2C receptor agonist, ( S)-2-chloro-5-fluoro-indol-1-yl)-1-methyl ethylamine fumarate (RO 60 0175), in three models of anxiety were therefore tested. RO 60 0175 was found to induce hypolocomotion in rats at doses greater than 0.5 mg/kg s.c,, an effect reversed by the selective 5-HT2C receptor antagonist, SB-242084. RO 60 0175 did not elicit anxiolytic-like responses in the social interaction test under high light unfamiliar conditions, but suppressed both time spent in social interaction and locomotion at doses of 1 and 3 mg/kg s.c., suggesting a sedative response. In the Vogel conflict test, RO 60 0175 had no significant action on the number of shocks taken. In the Geller-Seifter test, RO 60 0175 (0.3 and 1 mg/kg s.c.) simultaneously reduced both unpunished and punished lever pressing, a profile consistent with sedation. Finally, RO 60 0175 was tested in a rat social interaction test under low light familiar conditions optimal for the detection of anxiogenic-like responses. At 1 and 3 mg/kg s.c., RO 60 0175 reduced both time spent in social interaction and concurrent locomotion, a profile more consistent with sedation than anxiogenesis. In conclusion, RO 60 0175 induced sedative-like responses via 5-HT2C receptor activation, but was neither anxiolytic, nor dearly anxiogenic at the doses tested. (C) 2000 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available